triazinate has been researched along with Brain Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, RS; Ho, DH; Leavens, M; Loo, TL; Lu, K; Stewart, DJ; Wang, YM; Yap, HY | 1 |
| Dinapoli, RP; Eagan, RT; Groover, RV; Hermann, RC; Layton, DD | 1 |
| Bisel, HF; Creagan, ET; Eagan, RT; Groover, RV; Herman, RC; Layton, DD | 1 |
3 other study(ies) available for triazinate and Brain Neoplasms
| Article | Year |
|---|---|
Central nervous system pharmacology of Baker's antifolate (NSC139105) in man.
Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Glioblastoma; Humans; Lung Neoplasms; Meningeal Neoplasms; Muscles; Sarcoma; Triazines | 1984 |
Carmustine and Baker's antifol combination chemotherapy for primary brain tumors progressive after irradiation and chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Blood Cell Count; Brain Neoplasms; Carmustine; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Triazines | 1984 |
Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Dianhydrogalactitol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Sugar Alcohols; Tomography, X-Ray Computed; Triazines | 1981 |